Jazz Pharmaceuticals plc — Director's Dealing 2019

Feb 28, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2019-02-25

Reporting Person: WILSON KAREN J (SVP, Finance & PAO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-02-25	Ordinary Shares	F	310	$126.25	Disposed	15693	Direct
2019-02-26	Ordinary Shares	F	230	$127.76	Disposed	15463	Direct

Footnotes

F1: Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.

F2: Includes 173 ordinary shares acquired on May 31, 2018 and 73 ordinary shares acquired on November 30, 2018 under a Section 423 Employee Stock Purchase Plan.